Firststring research, INC.: repurposing drugs in response to chemical threats (redirect)
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00030
- Awardee
-
Xequel Bio, Inc. UEI T4JKC8B27PJ7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $749,999
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $749,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Mt Pleasant, SC 29464, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $7,499 | |
| Original award | $742,500 |
About this award
Xequel Bio, Inc., doing business as FSR, was awarded a $749,999 firm fixed price definitive contract from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to support research under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 seeks host-directed therapeutic candidates to aid long-term outcomes from lung injury. Under the contract, FSR will pursue safety review of such candidates through Phase I and share data and commercialization plans with the goal of demonstrating safety. Performance will occur in Mount Pleasant, South Carolina through October 2023. No set aside designation was specified.
Quick answers
Who was awarded contract 75A50121C00030?
75A50121C00030 was awarded to Xequel Bio, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on March 25, 2021.
How much is contract 75A50121C00030 worth?
The government has obligated $749,999 on 75A50121C00030.
Was contract 75A50121C00030 competed?
The extent of competition for 75A50121C00030 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award